Quest Diagnostics
DGX
748 hedge funds and large institutions have $13.5B invested in Quest Diagnostics in 2020 Q2 according to their latest regulatory filings, with 127 funds opening new positions, 218 increasing their positions, 290 reducing their positions, and 87 closing their positions.
88% more call options, than puts
Call options by funds: $105M | Put options by funds: $56.1M
46% more first-time investments, than exits
New positions opened: 127 | Existing positions closed: 87
37% more capital invested
Capital invested by funds: $9.91B → $13.5B (+$3.63B)
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
5% more funds holding
Funds holding: 714 → 748 (+34)
4.13% less ownership
Funds ownership: 93.08% → 88.96% (-4.1%)
25% less repeat investments, than reductions
Existing positions increased: 218 | Existing positions reduced: 290
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$213M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$127M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$118M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$104M |
| 5 |
Millennium Management
New York
|
+$82.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$465M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$250M |
| 3 |
BlackRock
New York
|
-$128M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$107M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
-$82.8M |
DGX Hedge Fund Activity: Q2 2020 in Review
748 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q2 2020, worth a combined $13.5B — up 37% from $9.91B a quarter earlier.
Buyers outnumbered sellers: 127 funds opened new DGX positions and 87 closed out — a net gain of 40 holders — while 218 added to existing stakes and 290 trimmed.
The largest buyer was Ameriprise, adding an estimated $213M. The largest seller was Victory Capital Management, cutting an estimated $465M.
- 748 institutional investors held Quest Diagnostics (DGX) as of Q2 2020, up from 714 in Q1 2020.
- Funds reported $13.5B of Quest Diagnostics stock for Q2 2020, up 37% quarter-over-quarter.
- 127 funds opened new Quest Diagnostics positions in Q2 2020 and 87 closed out, a net change of +40 holders.
- The largest Quest Diagnostics buyer in Q2 2020 was Ameriprise, an estimated $213M added.
- The largest Quest Diagnostics seller in Q2 2020 was Victory Capital Management, an estimated $465M sold.
Based on aggregated 13F filings for Q2 2020.